A.R.T. Advisors’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
FMI
DSA
A.R.T. Advisors's DGX Position: Q1 2020 in Review
A.R.T. Advisors sold out of Quest Diagnostics (DGX) in Q1 2020, closing a stake of 5,700 shares — an estimated $609K sold.
A.R.T. Advisors first reported a position in DGX in Q4 2013 and held it in 15 quarters. The position peaked at $6.56M in Q4 2013. 714 funds tracked by Wall St. Rank hold DGX as of Q1 2020.
- A.R.T. Advisors reported no remaining Quest Diagnostics position as of Q1 2020 after selling out during the quarter.
- A.R.T. Advisors sold 5,700 Quest Diagnostics shares in Q1 2020, an estimated $609K.
- A.R.T. Advisors first reported a position in Quest Diagnostics in Q4 2013 and held it in 15 quarters.
- A.R.T. Advisors's Quest Diagnostics position peaked at $6.56M in Q4 2013.
- 714 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2020.
Based on A.R.T. Advisors's 13F filing for Q1 2020, filed 15 May 2020.